Assessing linear CD4 declineQuantifying Diagnosis Delay following HIV seroconversion: Assessing the Linearity Assumption of CD4 Decline.

[1]  D. Nash,et al.  How to Evolve the Response to the Global HIV Epidemic With New Metrics and Targets Based on Pre-Treatment CD4 Counts , 2019, Current HIV/AIDS Reports.

[2]  Victor C. M. Leung,et al.  Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey , 2019, Journal of the International AIDS Society.

[3]  S. Braunstein,et al.  Increase in CD4+ T-Cell Count at the Time of HIV Diagnosis and Antiretroviral Treatment Initiation Among Persons With HIV in New York City. , 2016, The Journal of infectious diseases.

[4]  D. Costagliola,et al.  Looking Beyond the Cascade of HIV Care to End the AIDS Epidemic: Estimation of the Time Interval From HIV Infection to Viral Suppression , 2016, Journal of acquired immune deficiency syndromes.

[5]  Orl,et al.  Results from a Method for Estimating HIV Incidence Based on the FirstCd4 Count among Treatment-Naïve Cases: Brazil, 2004-2013 , 2016 .

[6]  S. Braunstein,et al.  Using HIV Viral Load From Surveillance to Estimate the Timing of Antiretroviral Therapy Initiation , 2016, Journal of acquired immune deficiency syndromes.

[7]  C. Szwarcwald,et al.  Brief report: Time from infection with the human immunodeficiency virus to diagnosis, United States. , 2015, Journal of acquired immune deficiency syndromes.

[8]  A. R. Pascom,et al.  Estimation of the HIV Incidence and of the Number of People Living With HIV/AIDS in Brazil, 2012 , 2015 .

[9]  S. Lamina,et al.  Effect of aerobic exercise training on cardiovascular parameters and CD4 cell count of people living with human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial. , 2014, Nigerian journal of clinical practice.

[10]  D. Pillay,et al.  Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  T. Bärnighausen,et al.  High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa , 2013, Science.

[12]  S. Braunstein,et al.  Integrating Acute HIV Infection within Routine Public Health Surveillance Practices in New York City , 2012, Public health reports (1974).

[13]  Anne M Johnson,et al.  Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Fidler,et al.  Universal Testing and Treatment as an HIV Prevention Strategy: Research Questions and Methods , 2011, Current HIV research.

[15]  Jim Young,et al.  Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies , 2010, PLoS medicine.

[16]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[17]  Ruiguang Song,et al.  Risk Factor Redistribution of the National HIV/AIDS Surveillance Data: An Alternative Approach , 2008, Public health reports.

[18]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[19]  J. J. Henning,et al.  Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.

[20]  A. Phillips,et al.  Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. , 1996, Genitourinary medicine.

[21]  J. Phair,et al.  Effect of CD4+ Cell Count Measurement Variability on Staging HIV‐1 Infection , 1992, Journal of acquired immune deficiency syndromes.

[22]  N. Pantazis,et al.  Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States , 2017, Journal of acquired immune deficiency syndromes.

[23]  Implementation of named HIV reporting--New York City, 2001. , 2004, MMWR. Morbidity and mortality weekly report.